Abstract
Objective
To perform meta-analyses evaluating the efficacy of adding Liuwei Dihuang Pills (六味地黄丸, LDP) to Western medicine in improving treatment outcomes for type 2 diabetes.
Methods
Medline, PubMed, Cochrane Library, and Chinese databases, including the Chinese National Knowledge Infrastructure were searched to identify eligible studies; i.e., if the study involved a randomized clinical trial in which the experimental group combined LDP with Western drugs and the control group used the corresponding Western drugs alone to treat type 2 diabetes. Outcomes were measured in terms of fasting blood glucose (FBG), postprandial blood glucose (2hPG) and HbA1c level. Efficacy was also measured by using control and response rates. The combined odds ratio (OR), mean difference (MD), and 95% confidence intervals (95% CI) were calculated.
Results
Studies included in the analysis were less adequate than expected in terms of methodological quality. A total of 1,609 patients from 18 studies were included. We found that adding LDP can lower patients’ FBG (MD=0.54 mmol/L, 95% CI [0.15, 0.93], P=0.007), 2hPG (MD=1.05 mmol/L, 95% CI [0.29, 1.81], P<0.01) and HbA1c (MD=0.23, 95% CI [0.02, 0.45], P=0.008). There were also improvements in treatment response rates (OR=3.41, 95% CI [2.38, 4.90], P<0.01) and control rates (OR=2.47, 95% CI [1.91, 3.20], P<0.01).
Conclusion
Adding LDP to Western medicine might improve treatment outcomes of diabetes, including FBG, 2hPG, response rates and control rates.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
References
Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011;378:31–40.
Xie Q. Research on the effect of Liuwei Dihuang Pills on treating type 2 diabetes. Clin J Chin Med (Chin) 2013;5:116–118.
Li KJ. Systematic assessment of RCTs on Six-Ingredient Rehmannia Pills’ efficacy in treating type 2 diabetes. Shandong J Tradit Chin Med (Chin) 2009;28:684–685.
Nicola Robinson. Integrative medicine — Traditional Chinese medicine, a model ? Chin J Integr med 2011;17:21–25.
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. The Cochrane Collaboration, 2011. Available from www.cochranehandbook.org.
Lin L. Standard of diagnosis and treatment of diabetes with combination of TCM and Western medicine. Chin J Integr Tradit West Med (Chin) 2005;25:94–95.
Zhang CX. Six-Ingredient Rehmannia Pills’ efficacy on diabetes. West China Med J (Chin) 2010;25:1137–1138.
Dai DY. A clinical trial on the efficacy of Six-Ingredient Rehmannia Pills and its modified prescriptions to treat type 2 diabetes. J Med Forum 2008;29(18):85–86.
Zhang FD. Thirty-eight trials on the combination of TCM and Western therapies to treat diabetes. Chin J Ethnomed Ethnopharm (Chin) 2010;126–127.
Gu GL. Adjuvant efficacy of Six-Ingredient Rehmannia Pills on the initial diagnosis of type 2 diabetes. J Community Med (Chin) 2011;9(7):41–42.
Jiang XL. Combination of TCM and Western therapies to treat obesity-related type 2 diabetes: an analysis of sixty cases. Chin J Celiopathy 2005;5:665–666.
Lang NQL, Wang HS. Clinical observation of type 2 diabetes treated with modified decoction of Six-Ingredient Rehmannia Pills. J Chengdu Univ Tradit Chin Med (Chin) 2000;23(4):46–47.
Lin YW. Efficacy of Six-Ingredient Rehmannia Pills and its modified prescriptions on type 2 diabetes. Zhejiang J Integr Tradit Chin West Med (Chin) 2002;12:373.
Lin Y, Chen SG. Combination of traditional Chinese medicine and Western therapies to treat diabetes: an analysis of thirty-eight cases. Modern Tradit Chin Med (Chin) 2010;30(1):16–17.
Liu S, Yang M, Zhang B. Impact of Six-Ingredient Rehmannia Pills combined with insulin pump on insulin sensitivity in the treatment of type 2 diabetes with yin-deficiency. J Pract Tradit Chin Intern Med (Chin) 2009;23(4):72–73.
Sun QH, Wang SQ. Clinical observance of sixty-two cases on the efficacy of Six-Ingredient Rehmannia Pills combined with diamicron to treat type 2 diabetes. Chin Modern Med Clin (Chin) 2006;5(2):10–11.
Wen LX, Chen CS. Fifty-eight clinical trials on Six-Ingredient Rehmannia Pills’ efficacy on type 2 diabetes. Chin Community Doctors (Chin) 2010;3:82.
Xi YP. Adjuvant efficacy of Six-Ingredient Rehmannia Pills and its modified prescriptions on type 2 diabetes: an analysis of forty-eight cases. Clin J Anhui Tradit Chin Med (Chin) 2002;14(1):5.
Zhang J. Combination of TCM and Western therapies to treat type 2 diabetes: an analysis of fifty-six cases. J Pract Tradit Chin Med (Chin) 2003;19(2):80.
Zhao ZY. Clinical observance of supplemented Six-Ingredient Rehmannia Pills’ efficacy on type 2 diabetes with qi and yin deficiency. China Foreign Med J (Chin) 2006;4(8):65–68.
Zhou JH, Yu QP. Combination of Six-Ingredient Rehmannia Pills and berberine in the treatment of senile diabetes: a clinical analysis of forty-eight cases. Strait Pharmac J (Chin) 1999;11(4):57–58.
Zou SC. Efficacy of glibenclamide and Six-Ingredient Rehmannia Pills on type 2 diabetes. Zhejiang J Integr Tradit Chin West Med (Chin) 2009;19:420–421.
Zhao M, Li W. Observation of Liuwei Dihuang Pill combined with glinides efficacy in the treatment of type 2 diabetes. Modern J Integr Tradit Chin West Med (Chin) 2013;22(1):47–49.
Dai F, Zhang JS. Observation of the effect of metformin combined with the SIRP in the treatment of type 2 diabetes. Pract J Cardiac Cerebr Pneumal Vasc Dis (Chin) 2012;20:1887.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Key Technology Research and Development Program of the People’s Republic of China (No. 2009BAI76B030900)
Rights and permissions
About this article
Cite this article
Pu, R., Geng, Xn., Yu, F. et al. Liuwei Dihuang Pills (六味地黄丸) enhance the effect of Western medicine in treating type 2 diabetes: A meta-analysis of randomized controlled trials. Chin. J. Integr. Med. 19, 783–791 (2013). https://doi.org/10.1007/s11655-013-1591-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-013-1591-7